Phoenix, AZ — May 10, 2011 — PEPID, the leading provider of developer drug data and clinical decision support information and technology for healthcare systems and professionals, today announced the addition of duplicate therapy checking to its robust drug interaction checker.

“As more and more drugs come on the market with multiple uses, and off label uses become more commonplace checking for duplicate therapy between medications is crucial, and must be considered in medication administration and prescribing.” says John Wagner, PEPID president. “We are excited to offer this new functionality to our users, as we continue to offer the full spectrum of clinical decision support through the PEPID Knowledge Base.”

PEPID’s drug interaction checker provides alerts for duplicate therapy on three different levels — therapeutic class, pharmacologic class and the ingredient level — making it the most comprehensive on the market today. This is in addition to the drug-drug, drug-allergy, drug-food and drug-herbal checks already available — solidifying the company’s position as the largest and most authoritative drug database on the market.

The duplicate therapy check will allow electronic medical record or pharmacy information systems to give users a warning if a duplicate therapy exists. This functionality helps to meet the requirements for meaningful use reimbursements.

PEPID’s reputable clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care, and this latest module adds to the robust content and tools available, and helps to meet meaningful use criteria in electronic medical records (EMR) systems.

PEPID content
is reviewed and contributed to by partners including the American Academy
of Emergency Medicine, the National Association of Emergency Medical Services
Educators, the Family Physician Inquiries Network, the National Association
of Clinical Nurse Specialists, the Oncology Nursing Society, and the American
Society of Health-System Pharmacists to ensure content is of the highest
quality.